SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Roader who wrote (909)5/22/1997 6:26:00 PM
From: Brad C. Dunlap   of 1762
 
Hi Roader, the secret to being right in any prediction into the future is to make your forecast and if proven wrong keep forecasting and at some point you stand a chance of being correct. That is about where I stand with my original statement of Eric Hecht of ML picking up coverage of Idec. I do believe it will happen but in hindsight ML had alot of stock that they sold from an old venture capital partnership and for compliance reasons would have put a delay in his actions. I really believed after ASCO we would have heard from ML but so far not a peep. I have a strong feeling that Smithkline is selling some more shares and I am speculating that Eric could be waiting for this potential overhang to work its way out. Nevertheless, alot of excuses but I still believe we'll see the day of his coverage on Idec.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News